Evidence map›Paper›PMID 26266414›Full record

Trial reportSensors (Basel, Switzerland)2015

Multi-Sensor Approach for the Monitoring of Halitosis Treatment via Lactobacillus brevis (CD2)-Containing Lozenges--A Randomized, Double-Blind Placebo-Controlled Clinical Trial.

Enrico Marchetti, Simona Tecco, Marco Santonico, Chiara Vernile, Daniele Ciciarelli, Ester Tarantino, Giuseppe Marzo, Giorgio Pennazza

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Sensors (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Interventions for managing halitosis.The Cochrane database of systematic reviews · 2019
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Effects of therapeutic probiotics on modulation of microRNAs.Cell communication and signaling : CCS · 2021
    Review
  7. Safety Evaluation of Oral Care ProbioticsInternational journal of molecular sciences · 2019
    Article
  8. Article
  9. Article
  10. Use of Probiotics and Oral Health.Current oral health reports · 2017
    Review
  11. Review of probiotic use in otolaryngology.American journal of otolaryngology
    Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Enrico MarchettiDepartment MESVA, University of L'Aquila, Via Vetoio ed. Delta 6, 67100 L'Aquila, Italy. enrico.marchetti@cc.univaq.it.
Simona TeccoUniversity Vita-Salute San Raffaele, I.R.R.C.S. San Raffaele Hospital, 20100 Milano, Italy. tecco.simona@hsr.it.
Marco SantonicoCenter for Integrated Research-CIR, Unit of Electronics for Sensor Systems, "Università Campus Bio-Medico di Roma", Via Alvaro del Portillo 21, 00128 Rome, Italy. m.santonico@unicampus.it.
Chiara VernileCenter for Integrated Research-CIR, Unit of Electronics for Sensor Systems, "Università Campus Bio-Medico di Roma", Via Alvaro del Portillo 21, 00128 Rome, Italy. c.vernile@unicampus.it.
Daniele CiciarelliDepartment MESVA, University of L'Aquila, Via Vetoio ed. Delta 6, 67100 L'Aquila, Italy. daky87@hotmail.it.
Ester TarantinoDepartment MESVA, University of L'Aquila, Via Vetoio ed. Delta 6, 67100 L'Aquila, Italy. ester88x@hotmail.it.
Giuseppe MarzoDepartment MESVA, University of L'Aquila, Via Vetoio ed. Delta 6, 67100 L'Aquila, Italy. giuseppe.marzo@cc.univaq.it.
Giorgio PennazzaCenter for Integrated Research-CIR, Unit of Electronics for Sensor Systems, "Università Campus Bio-Medico di Roma", Via Alvaro del Portillo 21, 00128 Rome, Italy. g.pennazza@unicampus.it.
University of L'Aquila · ITUniversità Campus Bio-Medico · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this randomized clinical trial was to evaluate whether a recently described multi-sensor approach called BIONOTE(®) is accurate enough to verify the efficacy of treatment of patients with halitosis. A treatment with Lactobacillus brevis (CD2)-containing lozenges, compared with placebo was tested. The BIONOTE(®) was compared with traditional techniques used to detect halitosis: OralChroma™ and two calibrated odor judges enrolled for the organoleptic assessments. Twenty patients (10 treated and 10 placebo), suffering from active phase halitosis were included in the study. Treatment consisted of Lactobacillus brevis (CD2)-containing lozenges or placebo, 4 tablets/day for 14 days. t0 was before the beginning of the study; t1 was day 7 and t2 was day 14. The effectiveness of treatment was assessed through: (1) Rosenberg score; (2) Winkel tongue coating index (WTCI) anterior and posterior; (2) OralChroma™; (3) the new developed multi-sensor approach, called BIONOTE(®) (test technique). Only the WTCI anterior revealed statistically significant changes between t0 and t2 data (p = 0.014) in the treated group. Except for the WTCI anterior, all diagnostic methods revealed the lack of effectiveness for halitosis of a 14-days treatment with Lactobacillus brevis (CD2)-containing lozenges. The BIONOTE(®) multisensor system seems accurate in addition to OralChroma™ to assess the initial condition of halitosis and its mitigation during treatment.

Indexed as

AdultBiosensing TechniquesDemographyDouble-Blind MethodHalitosisHumansLevilactobacillus brevisMalePlacebosTabletsTreatment OutcomePlacebosTabletsbad breathchemical sensorselectronic nosehalitosisprobioticssensor array

Identifiers

PMID26266414
PMCPMC4570386
OpenAlexW2120474733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.